Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen

Journal of Medical Virology

Volumn 67, Issue 3, 2002, Pages 375-383

  Heegaard, Erik D ^a,b,c   Rasksen, Cecilie J ^b   Christensen, Jesper ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antibody; Baculovirus expression system; Conformational epitopes; Diagnosis; Immunoglobulin; Sensitivity

Indexed keywords

EPITOPE; NONSTRUCTURAL PROTEIN 1; PROTEIN VP1; PROTEIN VP2; RECOMBINANT PROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VECTOR;

ANALYTIC METHOD; ANTIBODY DETECTION; ANTIGENICITY; ARTHRALGIA; ARTICLE; BACULOVIRUS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PARVOVIRUS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; BACULOVIRIDAE; BLOTTING, WESTERN; CAPSID; CAPSID PROTEINS; CELLS, CULTURED; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SPODOPTERA; VIRAL NONSTRUCTURAL PROTEINS;

PARVOVIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0036267522     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10079     Document Type: Article

References (35)

1. Candidate recombinant vaccine for human B19 parvovirus
2. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay
3. Haematological consequences of parvovirus B19 infection
4. Localization of an immunodominant domain on baculovirus-produced parvovirus B19 capsids: Correlation to a major surface region on the native virus particle
5. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments
6. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription
7. Baculovirus expression of parvovirus B19 (B19V) NS1: Utility in confirming recent infection
8. Chronic parvovirus infection mimicking myelodysplastic syndrome in a child with subclinical immunodeficiency
9. Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9
10. Transient pancytopenia preceding acute lymphoblastic leukaemia (pre-ALL) precipitated by parvovirus B19
11. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: Serologic cross-reactivity with erythrovirus B19
12. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
13. Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the nonstructural protein
14. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection
15. Antibodies to parvovirus B19 nonstructural protein are associated with chronic but not acute arthritis following B19 infection
16. Undenatured parvovirus B19 antigens are essential for the accurate detection ofparvovirus B19 IgG
17. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
18. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus
19. IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay
20. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins
21. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells
22. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity
23. Virus taxonomy: Classification and nomenclature of viruses
24. Novel transcription map for the B19 (human) pathogenic parvovirus
25. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells
26. The 3′ untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells
27. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions
28. Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies
29. Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: Implications for pathogenesis doubtful
30. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
31. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro
32. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen
33. Antibodies to parvovirus B19 NS-1 protein in infected individuals
34. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: Implications for pathogenesis
35. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response